Elli Yılda Hastalık Maliyeti Yayınlarının Haritalandırılması: Bibliyometrik Analiz ve Yayınların Görünümü

Öz

Araştırmanın amacı, elli yılda "hastalık maliyeti" yayınlarının haritasını çıkarmak, araştırma alanlarını belirlemek ve hastalık maliyeti yayınlarının bibliyometrik analizini yapmaktır. Veriler Nisan 2024'te Web of Science veri tabanından elde edilmiştir. Yayınların atıf sayısı, yıllara göre dağılımı gibi temel bilgiler Microsoft Excel ile çıkarılmış; haritalar VOSviewer sürüm 1.6.15 yazılım programı kullanılmıştır. Yayınlar 1975-2024 yılları arasında yayımlanmıştır; 2015-2024 Nisan tarihleri arasında toplam 879 yayın olduğu görülmüştür. Toplam 7601 yazar hastalık maliyetine ilişkin literatürün gelişmesine katkıda bulunmuştur. Yazarlar tarafından bu yayınlara toplam 36369 atıf yapılmıştır; 2022 yılı 3032 atıfla en çok atıf yapılan yıl olmuştur; Boncz I. yayınlara ve toplam bağlantı gücüne göre öne çıkan yazardır; Leigh, JP en çok atıf yapılan yazardır; onu Sebestyen, A. ve Koenig, H.H. takip etmektedir. İlk 10 yayın toplam 5352 atıf almıştır. Son elli yılda hastalığın maliyeti yayınlarında ve atıflarda önemli bir artış olduğu açıktır. Bu yayınların bağlamını anlamak, bu alanda çalışmak isteyen araştırmacılar için önemlidir.

Anahtar Kelimeler

• bibliyometrik analiz
• hastalık maliyeti
• haritalama

Mapping the Cost of Illness Publications in Five Decades: A Bibliometric Analysis and Publications Landscape

Abstract

The study aims to map the "cost-of-illness" publications over five decades, identify research areas and conduct a bibliometric analysis of publications on the cost of illness. Study data was obtained from Web of Science database in April 2024. The basic information such as the number of citations, and yearly distribution of publications was extracted with Microsoft Excel, and the VOSviewer version 1.6.15 software program was used for maps. The publications were published between 1975 and 2024; total 879 publications were published from 2015 to 2024 April. A total of 7601 authors have contributed to advancing the literature on cost of illness. A total of 36369 citations have been cited by authors; 2022 was most cited year with 3032 citations; Boncz I. is the prominent author based on publications and total link strength and Leigh, JP is the most cited author; followed by Sebestyen, A. and Koenig, H.H. The top 10 publications have a total of 5352 citations. There has been significant increase in publications and citations related to the cost of the disease in the last five decades. Understanding the context of these publications is essential for researchers who want to work in this field.

Keywords

• bibliometric analysis
• cost of illness
• mapping the cost of illness studies

Kaynakça

1. Aagja, J., Shome, S., & Chandra, A. (2023). A Bibliometric Analysis of Digital Health & Mobile Health Related Global Research Publications Publications. Hospital Topics, 101(4), 319–325. https://doi.org/10.1080/00185868.2022.2060155
2. Afroz, A., Alramadan, M. J., Hossain, M. N., Romero, L., Alam, K., Magliano, D. J., & Billah, B. (2018). Cost-Of-Illness Of Type 2 Diabetes Mellitus In Low And Lower-Middle Income Countries: A Systematic Review. BMC Health Services Research, 18(1), 1-10. https://doi.org/10.1186/s12913-018-3772-8
3. Al-Kindi, S., Al-Juhaishi, T., Haddad, F., Taheri, S., & Abi Khalil, C. (2015). Cardiovascular Disease Research Activity In The Middle East: A Bibliometric Analysis. Therapeutic Advances in Cardiovascular Disease, 9(3), 70–76. https://doi.org/10.1177/1753944715578585
4. Arnold, R. J. G. (2020). Cost of Illness. Pharmacoeconomics. Milton Park: CRC Press.
5. Barbu, L. (2023). Global Trends in The Scientific Research of the Health Economics: A Bibliometric Analysis from 1975 To 2022. Health Economics Review, 13(1), 1-20. https://doi.org/10.1186/s13561-023-00446-7
6. Bartsch, S. M., Ferguson, M. C., McKinnell, J. A., O’Shea, K. J., Wedlock, P. T., Siegmund, S. S., & Lee, B. Y. (2020). The Potential Health Care Costs and Resource Use Associated with COVID-19 In The United States. Health Affairs, 39(6), 927–935. https://doi.org/10.1377/hlthaff.2020.00426
7. Bellettini, B., & García-Marín, A. P. (2022). Economic Damage-Cost Analysis Caused by Insufficient Sanitation in Rural Ecuador. Engenharia Sanitaria e Ambiental, 27(4), 731–736. https://doi.org/10.1590/s1413-415220210073
8. Bommer, C., Heesemann, E., Sagalova, V., Manne-Goehler, J., Atun, R., Bärnighausen, T., & Vollmer, S. (2017). The Global Economic Burden of Diabetes in Adults Aged 20–79 Years: A Cost-Of-Illness Study. The Lancet Diabetes & Endocrinology, 5(6), 423–430. https://doi.org/10.1016/S2213-8587(17)30097-9

9. Boncz, I., & Sebestyén, A. (2006). Financial Deficits in The Health Services of the UK and Hungary. The Lancet, 368(9539), 917–918. https://doi.org/10.1016/S0140-6736(06)69369-0
10. Bornmann, L., & Daniel, H. (2008). What Do Citation Counts Measure? A Review of Studies On Citing Behavior. Journal of Documentation, 64(1), 45–80. https://doi.org/10.1108/00220410810844150
11. Bozdemir, E., & Taşlı, M. (2018). Investigation Terms of Bibliometric and Document of Disease Cost Analysis. Konuralp Medical Journal, 10(3), 408–419. https://doi.org/10.18521/ktd.449264
12. Byford, S. (2000). Economic Note: Cost of Illness Studies. BMJ, 320(7245), 1335–1335. https://doi.org/10.1136/bmj.320.7245.1335
13. Cao, M., Wang, L., Zhang, L., & Duan, J. (2021). Global Publication Trends and Hotspots of Molecular Biomarkers in DILI from 1991 to 2020: A 30-year Bibliometric Analysis. Science Progress, 104(1), 1–16. https://doi.org/10.1177/00368504211000535
14. Dagenais, S., Caro, J., & Haldeman, S. (2008). A Systematic Review of Low Back Pain Cost of Illness Studies in The United States and Internationally. The Spine Journal, 8(1), 8–20. https://doi.org/10.1016/j.spinee.2007.10.005
15. Dorsey, E. R. (2017). A Digital Journal for a Digital Era. Digital Biomarkers, 1(1), 1–3. https://doi.org/10.1159/000458512
16. Drummond, M., Sculpher, M., & Torrance, G. (2005). Methods for the Economic Evaluation of Health Care Programmes (4rd ed.). Oxford: Oxford University Press
17. Durand-Zaleski, I. (2008). Why Cost-Of-Illness Studies Are Important and Inform Policy. Vascular Medicine, 13(3), 251–253. https://doi.org/10.1177/1358863X08091738
18. Feig, C., Cheung, K. L., Hiligsmann, M., Evers, S. M. A. A., Simon, J., & Mayer, S. (2018). Best-Worst Scaling to Assess The Most Important Barriers And Facilitators For The Use Of Health Technology Assessment In Austria. Expert Review of Pharmacoeconomics & Outcomes Research, 18(2), 223–232. https://doi.org/10.1080/14737167.2017.1375407
19. García-Pérez, L., Linertová, R., Valcárcel-Nazco, C., Posada, M., Gorostiza, I., & Serrano-Aguilar, P. (2021). Cost-Of-Illness Studies in Rare Diseases: A Scoping Review. Orphanet Journal of Rare Diseases, 16(1), 1-11. https://doi.org/10.1186/s13023-021-01815-3
20. Gerkens, S., Crott, R., Cleemput, I., Thissen, J.-P., Closon, M. C., Horsmans, Y., & Beguin, C. (2008). Comparison of Three Instruments Assessing the Quality of Economic Evaluations: A Practical Exercise On Economic Evaluations of the Surgical Treatment of Obesity. International Journal of Technology Assessment in Health Care, 24(03), 318–325. https://doi.org/10.1017/S0266462308080422
21. Gomes, B., Calanzani, N., Curiale, V., McCrone, P., Higginson, I. J., & de Brito, M. (2013). Effectiveness and Cost-Effectiveness of Home Palliative Care Services for Adults with Advanced Illness And Their Caregivers. Cochrane Database of Systematic Reviews, 2022(7), 1-8 https://doi.org/10.1002/14651858.CD007760.pub2
22. Greenberg, D., Mohamed Ibrahim, M. I. B., & Boncz, I. (2014). What Are the Challenges in Conducting Cost-of-Illness Studies? Value in Health Regional Issues, 4, 115–116. https://doi.org/10.1016/j.vhri.2014.08.003
23. Gulamhussein, M. A., Sawe, H. R., Kilindimo, S., Mfinanga, J. A., Mussa, R., Hyuha, G. M., Rwegoshora, S., Shayo, F., Mdundo, W., Sadiq, A. M., & Weber, E. J. (2023). Out-Of-Pocket Cost for Medical Care of Injured Patients Presenting to Emergency Department of National Hospital in Tanzania: A Prospective Cohort Study. BMJ Open, 13(1), e063297. https://doi.org/10.1136/bmjopen-2022-063297
24. Gupta, B., Dhawan, S., & Mueen Ahmed, K. (2018). Digital Health Research: A Scientometric Assessment Of Global Publications Output During 2007–2016. International Journal of Pharmaceutical Investigation, 8(2), 106-115. https://doi.org/10.4103/jphi.JPHI_31_18
25. Hanly, P., Ahern, M., Sharp, L., Ursul, D., & Loughnane, G. (2022). The Cost Of Lost Productivity Due To Premature Mortality Associated With COVID-19: a Pan-European Study. The European Journal of Health Economics, 23(2), 249–259. https://doi.org/10.1007/s10198-021-01351-8
26. Harter, S. P., & Kim, H. J. (1997). ARCHIVE: Electronic Journals and Scholarly Communication: A Citation and Reference Study. The Journal of Electronic Publishing, 3(2), 507-516. https://doi.org/10.3998/3336451.0003.212
27. Heijink, R., Noethen, M., Renaud, T., Koopmanschap, M., & Polder, J. (2008). Cost Of Illness: An International Comparison. Health Policy, 88(1), 49–61. https://doi.org/10.1016/j.healthpol.2008.02.012
28. Hernandez-Villafuerte, K., Li, R., & Hofman, K. J. (2016). Bibliometric Trends Of Health Economic Evaluation In Sub-Saharan Africa. Globalization and Health, 12(1), 1-15. https://doi.org/10.1186/s12992-016-0188-2
29. Hex, N., MacDonald, R., Pocock, J., Uzdzinska, B., Taylor, M., Atkin, M., Wild, S. H., Beba, H., & Jones, R. (2024). Estimation Of The Direct Health And Indirect Societal Costs Of Diabetes In The UK Using A Cost Of Illness Model. Diabetic Medicine, 41(9), 1-8. https://doi.org/10.1111/dme.15326
30. Hodgson, T. A., & Meiners, M. R. (1982). Cost-of-Illness Methodology: A Guide to Current Practices and Procedures. The Milbank Memorial Fund Quarterly. Health and Society, 60(3), 429-462. https://doi.org/10.2307/3349801
31. Hoffmann, S., Batz, M. B., & Morris, J. G. (2012). Annual Cost of Illness and Quality-Adjusted Life Year Losses in the United States Due to 14 Foodborne Pathogens. Journal of Food Protection, 75(7), 1292–1302. https://doi.org/10.4315/0362-028X.JFP-11-417
32. Ibáñez, B., & Rodés-Cabau, J. (2019). Present And Future Of Medical Journals. REC Interv Cardiol, 1, 11-12. https://doi.org/10.24875/RECICE.M19000005
33. Jo, C. (2014). Cost-Of-Illness Studies: Concepts, Scopes, And Methods. Clinical And Molecular Hepatology, 20(4), 327-337. https://doi.org/10.3350/cmh.2014.20.4.327
34. Johnson, J. A. (1995). Drug-Related Morbidity And Mortality. A Cost-Of-Illness Model. Archives of Internal Medicine, 155(18), 1949–1956. https://doi.org/10.1001/archinte.155.18.1949
35. Karahan, O., & Aslan, A. (2020). Scientificity and H-Index. Acta Medica Alanya, 4(1), 1–2. https://doi.org/10.1038/embor.2008.233
36. Kessler, R. C., Ames, M., Hymel, P. A., Loeppke, R., McKenas, D. K., Richling, D. E., Stang, P. E., & Ustun, T. B. (2004). Using the World Health Organization Health and Work Performance Questionnaire (HPQ) to Evaluate the Indirect Workplace Costs of Illness. Journal of Occupational & Environmental Medicine, 46(6), 23–37. https://doi.org/10.1097/01.jom.0000126683.75201.c5
37. Khanra, S., Dhir, A., Parida, V., & Kohtamäki, M. (2021). Servitization Research: A Review And Bibliometric Analysis Of Past Achievements And Future Promises. Journal Of Business Research, 131, 151–166. https://doi.org/10.1016/j.jbusres.2021.03.056
38. Kim, Y.-E., Jung, Y.-S., Ock, M., & Yoon, S.-J. (2022). DALY Estimation Approaches: Understanding and Using the Incidence-based Approach and the Prevalence-based Approach. Journal of Preventive Medicine and Public Health, 55(1), 10–18. https://doi.org/10.3961/jpmph.21.597
39. Krol, M., Brouwer, W., & Rutten, F. (2013). Productivity Costs in Economic Evaluations: Past, Present, Future. PharmacoEconomics, 31(7), 537–549. https://doi.org/10.1007/s40273-013-0056-3
40. Leigh, J. P. (1997). Occupational Injury And Illness In The United States. Estimates Of Costs, Morbidity, And Mortality. Archives Of Internal Medicine, 157(14), 1557–1568. https://doi.org/10.1001/archinte.157.14.1557
41. Lewis, R. C., & Pizam, A. (1986). Designing Research For Publication. Cornell Hotel And Restaurant Administration Quarterly, 27(2), 56–61. https://doi.org/10.1177/07399863870092005
42. Li, X., Wu, L., Yu, L., He, Y., Wang, M., & Mu, Y. (2023). Policy Analysis In The Field Of Rare Diseases In China: A Combined Study Of Content Analysis And Bibliometrics Analysis. Frontiers in Medicine, 10, 1-14. https://doi.org/10.3389/fmed.2023.1180550
43. Man, J. P., Weinkauf, J. G., Tsang, M., & Sin, J.H.D.D. (2004). Why do Some Countries Publish More Than Others? An International Comparison of Research Funding, English Proficiency and Publication Output in Highly Ranked General Medical Journals. European Journal of Epidemiology, 19(8), 811–817. https://doi.org/10.1023/B:EJEP.0000036571.00320.b8
44. Mattingly II, T. J., & Weathers, S. (2022). Drug Costs In Context: Assessing Drug Costs In Cost-Of-Illness Analyses. Drugs In Context, 11, 1–7. https://doi.org/10.7573/dic.2022-5-4
45. Mejia, N., Ramani, E., Pallas, S. W., Song, D., Abimbola, T., & Mogasale, V. (2020). Methodological Considerations for Cost of Illness Studies of Enteric Fever. Clinical Infectious Diseases, 71(Supplement_2), 111–119. https://doi.org/10.1093/cid/ciaa481
46. Munir, J., Faiza, M., Jamal, B., Daud, S., & Iqbal, K. (2023). The Impact of Socio-economic Status on Academic Achievement. Journal of Social Sciences Review, 3(2), 695–705. https://doi.org/10.54183/jssr.v3i2.308
47. Nakhaee, M., Khandehroo, M., & Esmaeili, R. (2024). Cost of Illness Studies in COVID-19: a scoping review. Cost Effectiveness and Resource Allocation, 22(1), 1-9. https://doi.org/10.1186/s12962-024-00514-7
48. Namdari, S., Baldwin, K., Kovatch, K., Huffman, G. R., & Glaser, D. (2012). Fifty Most Cited Articles In Orthopedic Shoulder Surgery. Journal of Shoulder and Elbow Surgery, 21(12), 1796–1802. https://doi.org/10.1016/j.jse.2011.11.040
49. Ng, C. S., Lee, J. Y. C., Toh, M. P., & Ko, Y. (2014). Cost-of-Illness Studies Of Diabetes Mellitus: A Systematic Review. Diabetes Research and Clinical Practice, 105(2), 151–163. https://doi.org/10.1016/j.diabres.2014.03.020
50. Oderda, G. M. (2003). Cost-of-Illness Studies. Journal of Pain & Palliative Care Pharmacotherapy, 17(1), 59–62. https://doi.org/10.1080/J354v17n01_08
51. Onat, A. (2011). Which Fields and Articles Contributed Most to Medicine from Turkey? Marmara Medical Journal, 24, 156–161. https://doi.org/10.5472/MMJ.2011.01988.1
52. Onukwugha, E., McRae, J., Kravetz, A., Varga, S., Khairnar, R., & Mullins, C. D. (2016). Cost-of-Illness Studies: An Updated Review of Current Methods. PharmacoEconomics, 34(1), 43–58. https://doi.org/10.1007/s40273-015-0325-4
53. Pitt, C., Goodman, C., & Hanson, K. (2016). Economic Evaluation in Global Perspective: A Bibliometric Analysis of the Recent Literature. Health Economics, 25(S1), 9–28. https://doi.org/10.1002/hec.3305
54. Schnitzler, L., Jackson, L. J., Paulus, A. T. G., Roberts, T. E., & Evers, S. M. A. A. (2021). Intersectoral Costs Of Sexually Transmitted Infections (Stis) And HIV: A Systematic Review Of Cost-Of-Illness (COI) Studies. BMC Health Services Research, 21(1), 1179-1189. https://doi.org/10.1186/s12913-021-07147-z
55. Smith, E., Haustein, S., Mongeon, P., Shu, F., Ridde, V., & Larivière, V. (2017). Knowledge Sharing In Global Health Research – The Impact, Uptake And Cost Of Open Access To Scholarly Literature. Health Research Policy And Systems, 15(1), 1-10. https://doi.org/10.1186/s12961-017-0235-3
56. Tam, T. (2018). Building Collaborations To Integrate Economics Into Noncommunicable Disease Action. Revista Panamericana De Salud Pública, 42, 1-3. https://doi.org/10.26633/RPSP.2018.36
57. Valero, A., & Van Reenen, J. (2019). The Economic Impact Of Universities: Evidence From Across The Globe. Economics Of Education Review, 68, 53–67. https://doi.org/10.1016/j.econedurev.2018.09.001
58. van Tulder, M. W., Koes, B. W., & Bouter, L. M. (1995). A Cost-Of-Illness Study Of Back Pain In The Netherlands. Pain, 62(2), 233–240. https://doi.org/10.1016/0304-3959(94)00272-G
59. Wang, L., Si, L., Cocker, F., Palmer, A. J., & Sanderson, K. (2018). A Systematic Review of Cost-of-Illness Studies of Multimorbidity. Applied Health Economics and Health Policy, 16(1), 15–29. https://doi.org/10.1007/s40258-017-0346-6
60. Xu, Z. L., & Zhang, X. (2005). Science and Scientificity. Genomics, Proteomics and Bioinformatics, 3(4), 197–200. https://doi.org/10.1016/S1672-0229(05)03026-3
61. You, Y., Shou, X., Zhang, X., Fan, S., Chai, R., Xue, W., Hu, Y., & He, Q. (2022). Psycho-Cardiological Disease: A Bibliometric Review From 2001 to 2021. Frontiers in Cardiovascular Medicine, 9. https://doi.org/10.3389/fcvm.2022.890329